Saccharo
PrivateCompany Overview
Saccharo is a biotechnology company that develops a pipeline of cancer therapies targeting a novel polysaccharide based immune shielding pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
antibody-drug conjugateADCglycan targetingimmuno-oncologydPSA targetIOglyco-oncologyfirst-in-class therapypreclinical biotechoncology startupsolid tumor therapyhematologic cancerdrug licensingpharma partnershipsde-N-acetyl-polysialic acid
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saccharo Comparables
Compare Saccharo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlyTR Therapeutics | 80% | |
| Palleon Pharmaceuticals | 78% | |
| Tacalyx | 78% | |
Saccharo Funding Rounds
Historical fundraising activity
Saccharo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Saccharo's valuation, stock price, and market status.
Firmographic Details
HeadquartersOakland, California
Employee Range6
Year Founded2017
Last Funding—
See something wrong or outdated?